Contact Us
News

Sterne Kessler Focuses on Pharma

Sterne Kessler Focuses on Pharma

IP firm Sterne, Kessler, Goldstein & Fox recently brought together guests from pharma companies worldwide for two days to "Focus on Pharma: Creating, Protecting & Enforcing High-Value IP Assets." Here, director H. Keeto Sabharwal gives opening remarks discussing key objectives.

Sterne Kessler Focuses on Pharma

The conference focused on trends in substantive case law, their impact on patent prosecution and examination, and implications regarding the enforcement of patents in the pharmaceutical and biopharmaceutical industry. This panel discussed the ins-and-outs of pharmaceutical litigation.

Sterne Kessler Focuses on Pharma

The last time we saw this many Ph.D.s in one room was when we snuck into Paul Krugman's Nobel Prize celebration kegger. Sterne Kessler directors Marsha Rose Gillentine, Ph.D., Eric Steffe, and panelists discussed patent prosecution and the America Invents Act. Johnson & Johnson SVP of IP Policy & Strategy Philip Johnson gave the keynote. Other speakers included the firm directors Jorge Goldstein, Ph.D.; Paul Ainsworth; Dennies Varughese, Pharm. D.; Eldora Ellison, Ph.D.; Deborah Sterling, Ph.D.; Paul Calvo, Ph.D.; Timothy Shea Jr.; and Monica Riva Talley.

Related Topics: Sterne Kessler
WASHINGTON DC 09.14.2017

7TH ANNUAL FUTURE OF PRINCE GEORGE'S COUNTY

Exclusive Bisnow Cocktail Hour to Follow Panels!

Jane Cafritz
Calvin Cafritz Enterprises
Steve Schwat
Urban Investment Partners (UIP)
Nina Albert
Washington Metropolitan Area Transit Authority (WMATA)